The FDA issued recent updates regarding drugs that are currently in shortage or have been discontinued:
- Amino Acids (Updated – Currently in Shortage)
- Atenolol Tablets (Updated – Currently in Shortage)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Betaine Hydrochloride (Cystadane) for Oral Solution (Updated – Resolved)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Chloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Cefepime Injection (Updated – Currently in Shortage)
- Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Dextrose 50% Injection (Updated – Currently in Shortage)
- Diltiazem Hydrochloride (Updated – Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated – Currently in Shortage)
- Dopamine Hydrochloride Injection (Updated – Currently in Shortage)
- Dorzolamide Hydrochloride Ophthalmic Solution (Updated – Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Heparin Sodium and Sodium Chloride 0.9% Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketamine Injection (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Liothyronine Sodium Tablets (New – Discontinuation)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Metronidazole Injection, USP (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Potassium Phosphate Injection (Updated – Currently in Shortage)
- Procainamide Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Progesterone Injection, USP (Updated – Currently in Shortage)
- Remifentanil (Ultiva) Lyophilized Powder for Solution Injection (Updated – Currently in Shortage)
- Sodium Acetate Injection, USP (Updated – Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Thioridazine Hydrochloride Tablets (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
